The Impact of Digital Transformation on the Ventilator-associated pneumonia (VAP) Industry
Global Ventilator-associated Pneumonia (VAP) Market - Overview
Patients in critical care require aid for respiration. Many of them suffer from disease like heart disease which require continuous monitoring by healthcare staff in intensive care unit. Ventilator- associated pneumonia is prevalent among patients admitted to ICUs. It is a significant cause of morbidity and mortality in ICU.
Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/1377
This disease results from contaminated pathogen secretions in the lungs. Prolonged use of ventilators in ICU favor the growth of this market. Increase in hospital acquired infection is also another factor contributing for the growth of this market. Prevention of ventilator-associated pneumonia is important to protect the health of patients suffering from life threating diseases.
Global Ventilator-associated Pneumonia (VAP) Market - Competitive Analysis
Philips Healthcare is one of the major market player in ventilation devices with its products named Respironic NM3, Respironic V680 and Respironic Trilogy 202.Medtronic plc. Is another major market player in this market with product like Puritan Bennet 980, Newport HT70 and Newport e360.ResMed manufactures ventilation devices named Astral 150 and Astral 100?
Global Ventilator-associated pneumonia (VAP) Market - Regional Analysis
Globally, Ventilator-associated pneumonia (VAP) market consists of four regions Americas, Europe, Asia Pacific and Middle East & Africa. America is the largest market for Ventilator-associated pneumonia (VAP) whose growth is contributed to increase in prevalence of smoking leading to lung diseases, large number of patients suffering from chronic heart diseases and demand of mechanical ventilators.
Access Report Details with TOC @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377
The market is growing continuously in Europe due to extensive demand of medical devices in hospitals, and increasing healthcare expenditure. Asia Pacific is expected to be the fastest growing market owing to increase in environmental pollution, high incidence of asthma & chronic obstructive pulmonary disease and large patient pool.
Moreover, Awareness regarding prevention of hospital acquired infection, pneumonia and quality control measures taken by hospitals for control of nosocomial infection favor the growth of this market. Increasing ageing population and incidence of infectious disease too contribute for the growth of this market in Asia Pacific. On the other hand, the Middle East & Africa region are likely to have a limited but steady growth in the market.
Global Ventilator-associated pneumonia (VAP) -Major Points from TOC
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Ventilator-associated pneumonia (VAP) Market, By Type
Chapter 7. Global Ventilator-associated pneumonia (VAP) Market, By Treatment
Chapter 8 Global Ventilator-associated pneumonia (VAP) Market, By End User
Chapter 9. Global Ventilator-associated pneumonia (VAP) Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Avail Excusive Discount @ https://www.marketresearchfuture.com/check-discount/1377
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]